Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Inclusion of children and pregnant women in COVID-19 intervention trials

Inclusion of children and pregnant women in COVID-19 intervention trials www.nature.com/pr COMMENT Inclusion of children and pregnant women in COVID-19 intervention trials 1,2 3 4,5 6,7 Atul Malhotra , Arunaz Kumar , Charles C. Roehr and Maria C. den Boer Pediatric Research (2021) 89:1063–1064; https://doi.org/10.1038/s41390-020-1067-3 The novel coronavirus (SARS-CoV-2) presents a stiff challenge for participants was traditionally justified due to the unforeseen health professionals where information and research on ther- teratogenic risks to the fetus and adverse pregnancy outcomes of apeutic options for the virus and disease needs to keep abreast new medications. However, it has been argued that excluding with clinical management of patients. There are many re-purposed pregnant women from research participation can only be justified and new therapies being trialed for the prevention and treatment if the trial has no prospect of medical benefit to the pregnant of its clinical disease, COVID-19. A search of a trial registry woman, and the studied intervention has a known or plausibly (Clinicaltrials.gov) in April 2020 revealed more than 500 trials inferred risk of significant harm to the fetus. Although long- already registered for “SARS-CoV-2” or “COVID-19”. A manual standing consensus suggests that the inclusion of pregnant search of the inclusion and exclusion criteria of 250 registered women in research http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pediatric Research Springer Journals

Inclusion of children and pregnant women in COVID-19 intervention trials

Loading next page...
 
/lp/springer-journals/inclusion-of-children-and-pregnant-women-in-covid-19-intervention-3Y5HjYO1Gk

References (14)

Publisher
Springer Journals
Copyright
Copyright © International Pediatric Research Foundation, Inc 2020
ISSN
0031-3998
eISSN
1530-0447
DOI
10.1038/s41390-020-1067-3
Publisher site
See Article on Publisher Site

Abstract

www.nature.com/pr COMMENT Inclusion of children and pregnant women in COVID-19 intervention trials 1,2 3 4,5 6,7 Atul Malhotra , Arunaz Kumar , Charles C. Roehr and Maria C. den Boer Pediatric Research (2021) 89:1063–1064; https://doi.org/10.1038/s41390-020-1067-3 The novel coronavirus (SARS-CoV-2) presents a stiff challenge for participants was traditionally justified due to the unforeseen health professionals where information and research on ther- teratogenic risks to the fetus and adverse pregnancy outcomes of apeutic options for the virus and disease needs to keep abreast new medications. However, it has been argued that excluding with clinical management of patients. There are many re-purposed pregnant women from research participation can only be justified and new therapies being trialed for the prevention and treatment if the trial has no prospect of medical benefit to the pregnant of its clinical disease, COVID-19. A search of a trial registry woman, and the studied intervention has a known or plausibly (Clinicaltrials.gov) in April 2020 revealed more than 500 trials inferred risk of significant harm to the fetus. Although long- already registered for “SARS-CoV-2” or “COVID-19”. A manual standing consensus suggests that the inclusion of pregnant search of the inclusion and exclusion criteria of 250 registered women in research

Journal

Pediatric ResearchSpringer Journals

Published: Jul 20, 2020

There are no references for this article.